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INTRODUCTION
Pulmonary tuberculosis, despite of all 
knowledge gathered on its pathogenesis, epi-
demiology, and therapeutics over the years, 
remains an important public health problem 
in Brazil and other developing countries. 
Therefore, implementation of newer diag-
nostic methodologies and therapeutic meas-
ures are fundamental steps for the reduction 
of its morbidity and mortality among the 
patients and for stopping its transmission 
chain within the community.1 
Presently, the identification of Myco-
bacterium species relies on lengthy cultures 
and biochemical tests. Although molecular 
tests are available commercially, they are re-
stricted to certain types of patient samples 
or the species of Mycobacterium isolated in 
culture.2 
Patients with few bacilli depend strongly 
on the sputum culture for the definitive di-
agnosis, which takes on average three to six 
weeks to be accomplished.3 Hence, faster 
alternative techniques are desirable, and 
among them, the polymerase chain reaction 
(PCR) seems to be the most promising. 
PCR has popularized the use of molecu-
lar biology techniques in clinical laboratories 
for diagnosing many infectious diseases.4 
However, the performance of this technique 
depends considerably on the quality of the 
samples examined. Therefore, it would be of 
uttermost importance to know the influence 
of the sample quality in its performance, as 
well as determining criteria for acceptabil-
ity of the samples in the diagnosis using this 
technique.
ABSTRACT
Setting: faster alternative techniques are required to improve the diagnosis and control of pul-
monary tuberculosis. Objective: To evaluate the sample quality in the performance of PCR 
for diagnosis of pulmonary tuberculosis. Method: during one year, sputum samples were col-
lected from 72 pulmonary tuberculosis patients and 12 non-tuberculosis controls, which were 
admitted to the Nereu Ramos hospital, Florianópolis city, Brazil. The samples were subjected 
to Ziehl-Neelsen-stained sputum smear microscopy and Lowestein-Jensen medium culture, 
which were defined as gold standard tests for mycobacteria, and polymerase chain reaction 
(PCR). Those samples that presented more than 40% of viable cells and less than 25% of epi-
thelial cells were defined as high quality samples. Results: PCR showed sensitivity of 55.6%, 
specificity of 41.7%, positive predictive value of 85.1%, negative predictive value of 13.5%, 
and accuracy of 53.6%. High quality samples showed sensitivity of 72.4%, specificity of 50%, 
positive predictive value of 91.3%, negative predictive value of 20%, and accuracy of 69.7%. 
Low quality samples showed sensitivity of 44.2%, specificity of 37.5%, positive predictive value 
of 79.2%, negative predictive value of 11.1%, and accuracy of 43.1%. Conclusion: use of high 
quality samples improved significantly the PCR performance, especially on their sensitivity 
and positive predictive values.
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Polymerase Chain Reaction – PCR
DNA was extracted by the alkaline lysis method.4 Brief-
ly, the sputum was suspended in GTE (Glucose 50 mM, 
10 mM EDTA, Tris/Cl PH 8.0, 0 25 mM), followed by 
cell lysis with SDS 1 %/NaOH 0.2 M. The suspension 
was neutralized with potassium acetate 3M pH 4.8-5.0. 
Proteinase K 20mg/mL was then added to the suspen-
sion and DNA was extracted with phenol/chloroform/
isoamyl alcohol (25:24:1). The suspension was then 
treated with ethanol plus sodium chloride and centri-
fuged. The sediment was re-suspended in 20 μL of TE 
(10mM Tris pH 7.4, 1 mM EDTA) and kept at -20° C 
until use.
The primer anti-sense MYC-264 and the primer sense 
F-285, which amplify a 1027 pair fragment of gene 16S 
rDNA from mycobacteria, were used in the PCR.6,7 The 
following conditions were met: 94° C for one minute, 
60° C for one minute, 35 cycles of one minute at 72° C, 
and one final cycle of 94° C for one minute, 60° C for 
one minute and 72° C for ten minutes. The amplification 
products were electrophoresed on a 1% (w/v) agarose 
gel, stained by ethidium bromide (1 μg/mL) and pho-
tographed under 320 ηm ultra-violet light (HOEFER- 
MacroVue UV-20), using a gel photodocumentation 
(DOC-PRINT® Biosystems). Their approximate size was 
determined by comparing it with 100 pb molecular size 
standard (Invitrogen).
Positive controls included DNA from Calmette-
Guérin bacillus (BCG) or Mycobacterium avium 
(ATCC-25291); negative controls included DNA from 
Escherichia coli (ATCC-25922) or pure water. As ad-
ditional control, a PCR amplification of AFB-negative 
samples was done with primers specific for eubacteria 
ZR-244 e F-285.7 
STUDY POPULATION AND METHODS
During one year, 72 pulmonary tuberculosis inpatients 
of hospital Nereu Ramos, Florianópolis city, Brazil, 
had their sputum evaluated. In addition, twelve non-
tuberculosis inpatients were used as controls. The study 
was approved by the Human Ethic Committee of Uni-
versity of South of Santa Catarina, under the number 
05.458.4.01.III. 
The samples were collected in the morning, before 
breakfast, and sent as soon as possible to the laboratory. 
They were subjected to smear and culture for mycobac-
teria (both used as gold standard), and to PCR for my-
cobacteria. 
Sputum smear 
The sputum smears were stained by the Ziehl-Neelsen 
technique and examined according to the guidelines of the 
World Health Organization.5 Briefly, heat-fixed sputum 
was stained with hot carbol fuchsin, decolorized with acid 
alcohol and then counterstained with methylene blue. 
Culture of mycobacteria in Löwenstein-Jensen 
(LJ) medium
The samples were subjected to culture according the 
Petroff protocol.5 Briefly, the samples were mixed with 
NaOH 4% (v/v), thoroughly shaken, and incubated for 
30 minutes at 35°-37° C. Then, sterile distilled water 
(v/v) was added to the sample and the suspension was 
neutralized with 1 N HCl, containing 0.004% of phenol 
red. The suspension was then centrifuged at 3,000 x g for 
20 minutes, and the sediment was resuspended in 500 μL 
of saline. A hundred microliters of the sediment was then 
inoculated onto two LJ medium slopes. The tubes were 
incubated at 35°-37° C for up to eight weeks, when the 
tubes with no growth were discarded as negative.
Table 1. Results of PCR for high and low quality samples
                                                 Pulmonary TB Samples                                      Control Samples
 High quality Low quality High quality Low quality Total
 n(%) n(%)  n(%) n(%) 
PCR (+) 21(25) 19(22.6) 2(2.4) 5(5.9) 47(56)
PCR (-) 8(9.5) 24(28.6) 2(2.4) 3(3.6) 37(44)
Total  29(34.5) 43(51.2) 4(4.8) 8(9.5) 84(100)
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Quality of sputum samples
High quality samples were defined as those with more 
than 40% of viable cells and less than 25% of epithelial 
cells. The viability of cells and the percentage of epithe-
lial cells were determined according to Pizzichini et al. 
and Lee et al., respectively.8,9
Performance of PCR
Sensitivity, specificity, positive predictive value, negative 
predictive value, and accuracy of PCR were calculated by 
the software SPSS16.0®, using the results of culture and 
sputum smear as gold standard. 
RESULTS
Thirty-three samples (39.3%) were of high quality, while 
fifty-one samples (60.7%) were of low quality. PCR was 
positive in 47 (56%) patients and negative in 37 (44%) 
patients. Table 1 shows the results of the PCR in high and 
low quality samples, respectively. 
When all samples were tested together, PCR showed 
sensitivity of 55.6%, specificity of 41.7%, positive predic-
tive value of 85.1%, negative predictive value of 13.5%, and 
accuracy of 53.6%. In samples of high quality, PCR showed 
a sensitivity of 72.4%, specificity 50%, positive predictive 
value of 91.3%, negative predictive value of 20%, and ac-
curacy of 69.7%. In samples of low quality, PCR showed a 
sensitivity of 44.2%, specificity of 37.5%, positive predic-
tive value of 79.2%, negative predictive value of 11.1%, and 
accuracy of 43.1% (Table 2). 
DISCUSSION
The results of this study show that the quality of the spu-
tum influences significantly the performance of PCR for 
the diagnosis of pulmonary tuberculosis. The selection 
of samples of high quality resulted in an improved PCR, 
especially when the sensitivity and positive predictive 
value parameters where taken into account. High quality 
samples presented sensitivity similar to that found into 
another study of clinical samples, which used primers 
specific for the IS6110 region of M. Tuberculosis.10 
Low quality sputum can represent a problem in the 
daily diagnosis routine. At least 25% of sputum samples 
sent to laboratories for culture may not be adequate, 
since some of them are sometimes heavily contaminated 
with saliva, leading to great variability in results and low 
reliability.11,12
PCR assay reduces the time for diagnosis and may 
increase the detection of mycobacteria in samples with 
negative smear results. However, variations in the proce-
dures of in-house PCR could explain the widely variabil-
ity of the sensitivity and specificity reported in several 
studies.13,14,15 
The influence of respiratory tract microbiota on the 
performance of PCR remains disputable. According to 
some authors, fungi and bacteria from these sites can af-
fect the results of PCR from sputum.16 However, others 
have reported high PCR sensitivity and specificity for 
tuberculosis diagnosis, despite the fact that the samples 
were clearly contaminated with these microorganisms.17 
In our study, we utilized only one sample for the same 
sputum. However, we could change this protocol, since 
some authors suggest that the sensitivity could be in-
creased if the assay could be done with more samples for 
the same sputum.18,19 
When testing the samples, we were not able to dif-
ferentiate among different species of Mycobacterium be-
cause the amplified region is conserved in all species of 
the genus. Unlike other regions amplified, 16SrDNA ex-
presses itself in fewer copies than the IS6110 sequences, 
but its amplification allows the rapid identification of 
subtypes by heteroduplex technique, which is in agree-
ment with the objectives of this study.20,21,22 
Table 2. Performance of PCR for high quality and low quality samples
 Total  High Quality Low Quality 
 samples samples samples
Sensitivity 55.6 72.4 44.2
Specificity 41.7 50 37.5
Positive predictive value 85.1 91.3 79.2
Negative predictive value 13.5 20 11.1
Accuracy 53.6 69.7 43.1
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Besides the amplified region, other factors such as the 
amount of bacilli can influence the performance of PCR. 
In this regard, Wu et al, using nested-PRA for hsp65 gene, 
identified 100% of the samples with 3 + of bacilli, 95% of 
samples with 2 + bacilli, and only 53% of samples with 
1 + or less bacilli.23 
The fact that this study used sputum instead of cul-
ture may have contributed to lower results than those re-
ported in the literature. However, the purpose of using 
sputum was an attempt to improve the technique effi-
ciency in this type of sample by speeding up the diagno-
sis without the need for the culture.
CONCLUSION
Our results indicate that selection of samples of high 
quality resulted in an improvement in performance of 
PCR for the diagnosis of pulmonary TB, especially re-
garding its sensitivity and positive predictive value pa-
rameters.
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